Frankfurt vs Chicago: Futures fight rumbles on in the courts

duncan-wood

CME Group is a big, successful company – too big, according to some. Speaking to Risk earlier this year, Michael Spencer, the chief executive of interdealer broker Icap, called it a monopoly and said he was astonished that the US Department of Justice (DOJ) considers that acceptable: “You have to reflect on how powerful the Chicago lobby is to enable that to continue,” he said.

This is a familiar refrain among over-the-counter market participants, but push past the shadowy, non-specific claims

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: